In summary, our work revealed and comprehensively validated the promoting role of STAU2‐PALLD axis in the progression and metastasis of pancreatic cancer (Figure 8K), suggesting that STAU2 as a novel drug target for therapeutic intervention. The gene discussed is PALLD; the disease is familial pancreatic carcinoma.